Müller Glia Co-Regulate Barrier Permeability with Endothelial Cells in an Vitro Model of Hyperglycemia
International Journal of Molecular Sciences · 15.11.2024 · 25 (22) · 12271
DOI: 10.3390/ijms252212271 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.11.2024. Verfasst von Juan S Peña und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Rutgers, The State University of New Jersey, 599 Taylor Road, Piscataway, NJ 08854, USA. Hauptthemen laut MEDLINE: Hyperglycemia, Endothelial Cells, Reactive Oxygen Species, Glycation End Products, Advanced. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation, New Jersey Health Foundation, U.S. National Science Foundation.
Abstract (Originalsprache)
Diabetic retinopathy is a complex, microvascular disease that impacts millions of working adults each year. High blood glucose levels from Diabetes Mellitus lead to the accumulation of advanced glycation end-products (AGEs), which promote inflammation and the breakdown of the inner blood retinal barrier (iBRB), resulting in vision loss. This study used an in vitro model of hyperglycemia to examine how endothelial cells (ECs) and Müller glia (MG) collectively regulate molecular transport. Changes in cell morphology, the expression of junctional proteins, and the reactive oxygen species (ROS) of ECs and MG were examined when exposed to a hyperglycemic medium containing AGEs. Trans-endothelial resistance (TEER) assays were used to measure the changes in cell barrier resistance in response to hyperglycemic and inflammatory conditions, with and without an anti-VEGF compound. Both of the cell types responded to hyperglycemic conditions with significant changes in the cell area and morphology, the ROS, and the expression of the junctional proteins ZO-1, CX-43, and CD40, as well as the receptor for AGEs. The resistivities of the individual and dual ECs and MG barriers decreased within the hyperglycemia model but were restored to that of basal, normoglycemic levels when treated with anti-VEGF. This study illustrated significant phenotypic responses to an in vitro model of hyperglycemia, as well as significant changes in the expression of the key proteins used for cell–cell communication. The results highlight important, synergistic relationships between the ECs and MG and how they contribute to changes in barrier function in combination with conventional treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Rutgers, The State University of New Jersey, 599 Taylor Road, Piscataway, NJ 08854, USA.
ORCID-Profile: Juan S Peña, Maribel Vazquez
Förderung
- National Science Foundation
- New Jersey Health Foundation
- U.S. National Science Foundation
Zitieren
APA
Peña, J. S., Berthiaume, F., & Vazquez, M. (2024). Müller Glia Co-Regulate Barrier Permeability with Endothelial Cells in an Vitro Model of Hyperglycemia. International Journal of Molecular Sciences, 25(22), 12271. https://doi.org/10.3390/ijms252212271
Vancouver
Peña JS, Berthiaume F, Vazquez M. Müller Glia Co-Regulate Barrier Permeability with Endothelial Cells in an Vitro Model of Hyperglycemia. International Journal of Molecular Sciences. 2024;25(22):12271. doi:10.3390/ijms252212271
BibTeX
@article{Pea2024,
author = {Peña, Juan S and Berthiaume, François and Vazquez, Maribel},
title = {Müller Glia Co-Regulate Barrier Permeability with Endothelial Cells in an Vitro Model of Hyperglycemia},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {22},
pages = {12271},
doi = {10.3390/ijms252212271}
}
EUVIMED